SARS-CoV-2 M <sup>pro</sup> inhibitors with antiviral activity in a transgenic mouse modelJingxin Qiao, Shengyong Yang, Yueshan Li et al.|Science|2021Cited by 449
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral targetBingqing Xia, Zhaobing Gao, Xiangrui Jiang et al.|Cell Research|2021Cited by 198
Scavenger Receptor C Mediates Phagocytosis of White Spot Syndrome Virus and Restricts Virus Proliferation in ShrimpMingchong Yang, Jin‐Xing Wang, Xiu-Zhen Shi et al.|PLoS Pathogens|2016Cited by 95
VH-CH1 switch region-inserting multispecific antibody designs and their efficacy against SARS-CoV-2 in vitro and in vivoLili Wu, Qihui Wang, Yue Gao et al.|Cell Discovery|2023Cited by 5
Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2Ling Xu, Yong‐Gang Yao|EBioMedicine|2024Cited by 1